HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fernandez, P. Articles by Ducassou, D. Search for Related Content PubMed PubMed Citation Articles by Fernandez, P. Articles by Ducassou, D.

Value of Captopril Renal Scintigraphy in Hypertensive Patients with Renal Failure

Service de Médecine Nucléaire et Néphrologie, Groupe Hospitalier Pellegrin, Bordeaux, France

Correspondence: For correspondence or reprints contact: Philippe Fernandez, MD, Service de Médecine Nucléaire, Groupe Hospitalier Pellegrin, Place Amélie Raba Léon, 33076 Bordeaux Cedex, France.

ABSTRACT

The aims of this study were to show the value of captopril renal scintigraphy for detecting a renovascular cause in hypertensive patients with renal failure and to assess the ability to predict the beneficial effect of revascularization on renal function. Methods: Thirty-eight patients with renal failure (mean glomerular filtration rate = 35 mL/min) underwent renal scintigraphy after injection of ^99mTc-mercaptoacetyltriglycine. Baseline scintigraphy was performed, and the test was repeated 24 h later after oral administration of 50 mg captopril given 60 min before the test. Results: In 5 of 6 patients with a renovascular cause for renal failure, and 2 of 3 patients with a probable arterial pathology, scintigraphy had a high probability. The result was indeterminate in the other 2 patients. In 5 of 11 patients with negative adenography and 14 of 18 patients with probable absence of renovascular pathology, we found a low probability of functional renal artery stenosis. Six revascularization procedures were performed and were predictive of a beneficial effect in 5 patients. Time of peak activity was an effective predictor in each case. Conclusion: In hypertensive patients with renal failure, captopril renal scintigraphy can detect hemodynamic dysfunction downstream from a renal artery stenosis and can predict the beneficial effect of revascularization in some cases.

Key Words: captopril renal scintigraphy • renal failure

This article has been cited by other articles:

				K. Wei, E. Le, J.-P. Bin, M. Coggins, J. Thorpe, and S. Kaul Quantification of renal blood flow with contrast-enhanced ultrasound J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1135 - 1140. [Abstract] [Full Text] [PDF]

				J. Radermacher, A. Chavan, J. Bleck, A. Vitzthum, B. Stoess, M. J. Gebel, M. Galanski, K. M. Koch, and H. Haller Use of Doppler Ultrasonography to Predict the Outcome of Therapy for Renal-Artery Stenosis N. Engl. J. Med., February 8, 2001; 344(6): 410 - 417. [Abstract] [Full Text] [PDF]